Loading clinical trials...

Cognitive-behavioral Therapy for Generalized Anxiety Disorder in Primary Care | Clinical Trials | Clareo Health

COMPLETEDNA

Cognitive-behavioral Therapy for Generalized Anxiety Disorder in Primary Care

Metacognitive Therapy and Intolerance of Uncertainty Therapy for Generalized Anxiety Disorder in Primary Care: Randomized Controlled Pilot Study

NCT03621371•Karolinska Institutet

View on ClinicalTrials.gov

Summary

The feasibilty and preliminary comparative effectiveness of two methods of cognitive-behavioral therapy - metacognitive therapy and intolerance of uncertainty therapy - for primary care patients with generalized anxiety disorder is investigated in a pilot study using a randomized controlled design. Purpose of the study is to examine the feasibility of a full-scale randomized controlled trial. Research questions primarily concern recruitment, measurement, and adherence.

Eligibility

Age

18 - 65 years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Primary diagnosis of generalized anxiety disorder
•Age 18 years or above
•Being able to understand and speak Swedish without interpreter support

Exclusion Criteria

•Psychosis, bipolar disorder, severe depressive symptoms, risk of suicid, substance use disorder, intellectual disability
•Simultaneous psychological treatment
•If pharmacological treatment, it needs to be stable prior to and during treatment

Locations (1)

Liljeholmen Primary Health Care Center

Stockholm, Sweden

Key Dates

Start Date

June 15, 2018

Primary Completion Date

November 30, 2019

Completion Date

November 30, 2019

Last Updated

January 30, 2025

Enrollment

ACTUAL participants

Conditions

Generalized Anxiety Disorder

Interventions

Metacognitive therapy

BEHAVIORAL

Intolerance of uncertainty therapy

BEHAVIORAL

Transcranial Alternating Current Stimulation for Generalized Anxiety Disorder and Insomnia: An Open-Label Pilot Study

NCT07429578

Generalized Anxiety Disorder (GAD)Chronic Insomnia

View study

RECRUITINGNA

Internet-Delivered Cognitive Behavioral Intervention for Youths With Anxiety Disorders

NCT06661460

ANXIETY DISORDERS (or Anxiety and Phobic Neuroses)Specific Phobia+5 more

View study

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: January 30, 2025Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions

Cognitive-behavioral Therapy for Generalized Anxiety Disorder in Primary Care

Inclusion Criteria

Exclusion Criteria

Transcranial Alternating Current Stimulation for Generalized Anxiety Disorder and Insomnia: An Open-Label Pilot Study

Internet-Delivered Cognitive Behavioral Intervention for Youths With Anxiety Disorders

Study to Assess Adverse Events and Change in Disease Activity When Oral ABBV-932 is Added to Antidepressant Therapies in Adult Participants With Generalized Anxiety Disorder

Prospective Clinical Trial of Crisugabalin Capsules in the Treatment of Generalized Anxiety Disorder

Teletherapy vs. In-Person Cognitive Behavioral Therapy for Generalized Anxiety Disorder

Electroclinical Correlation of Anxiety